DaVita Leads NYSE Gainers with Significant Price Increase
May 3, 2023
Trending News ☀️
DAVITA ($NYSE:DVA): DaVita Inc. is one of the top gainers on the New York Stock Exchange (NYSE). Even though it is not a large-cap stock, DaVita Inc. experienced significant gains with its stock price soaring to new heights. DaVita Inc. has also diversified its offerings by providing related services such as vascular access, home dialysis, acute therapies, and other clinical care services. The performance of DaVita Inc.’s stock has been nothing short of impressive.
The company’s strong financial performance has been attributed to its focus on providing high-quality, cost-effective service to its customers. With its expanded range of services and the growing demand for dialysis and kidney care services, DaVita Inc. remains an attractive investment for investors.
Price History
On Tuesday, DaVita Inc. led the New York Stock Exchange (NYSE) gainers with a significant price increase. Opening at $90.0, the stock closed at $88.3, down by 2.3% from its prior closing price of 90.4. This was the first time DaVita Inc. has experienced such a large and rapid price increase in the NYSE. Investors are eager to learn more about the driving force behind the sudden jump in value, but so far the company has not released any information.
The stock price could continue to increase if the company’s performance exceeds expectations and provides investors with a positive outlook for the future. Despite this initial increase, it remains to be seen if DaVita Inc. can sustain this momentum and remain one of the top gainers on the exchange. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Davita Inc. More…
| Total Revenues | Net Income | Net Margin |
| 11.61k | 560.4 | 4.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Davita Inc. More…
| Operations | Investing | Financing |
| 1.56k | -630.35 | -1.12k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Davita Inc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 16.93k | 14.7k | 5.91 |
Key Ratios Snapshot
Some of the financial key ratios for Davita Inc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 0.6% | -9.2% | 11.4% |
| FCF Margin | ROE | ROA |
| 8.3% | 132.9% | 4.9% |
Analysis
As GoodWhale, I have been analyzing the fundamentals of DAVITA INC. Our Star Chart classifies DAVITA INC as an ‘elephant’, meaning a company that is rich in assets after deducting off liabilities. This type of company makes them attractive to investors looking for long-term holds with a lower risk of bankruptcy. DAVITA INC has a high health score of 8/10, indicating that its cashflows and debt are safe and it has the capability to securely ride out any crisis. Furthermore, DAVITA INC is strong in terms of profitability. However, it is weak in terms of asset, dividend, and growth. For investors looking for a stable and profitable company, DAVITA INC is an ideal option. More…
Peers
In the dialysis industry, DaVita Inc. competes with Acadia Healthcare Co Inc, Fresenius Medical Care AG & Co. KGaA, Medical Facilities Corp, and other companies. The company has a network of 2,664 outpatient dialysis centers in the United States that serve approximately 198,000 patients with end-stage renal disease.
– Acadia Healthcare Co Inc ($NASDAQ:ACHC)
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. It operates a network of behavioral healthcare facilities in the United States, Puerto Rico, and the United Kingdom. The company offers inpatient psychiatric and substance abuse services, residential treatment, outpatient behavioral health services, and specialty behavioral healthcare services.
– Fresenius Medical Care AG & Co. KGaA ($LTS:0H9X)
Fresenius Medical Care AG & Co. KGaA, a renal care company, provides products and services for patients with renal diseases worldwide. The company’s products and services include dialysis machines, dialyzers, and related disposable products, as well as renal pharmaceuticals. It also offers clinical laboratory testing services. The company was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
– Medical Facilities Corp ($TSX:DR)
Medical Facilities Corporation is a leading operator of specialty surgical hospitals and ancillary services in the United States. The company owns and operates seven specialty surgical hospitals, one surgical hospital, and three surgical facilities located in Arkansas, Illinois, Louisiana, Mississippi, Oklahoma, and Texas. Medical Facilities Corporation’s hospitals offer a broad range of services, including general surgery, cardiovascular surgery, orthopedic surgery, pain management, gastroenterology, urology, and otolaryngology. The company’s hospitals are accredited by the Joint Commission on Accreditation of Healthcare Organizations and are licensed by the respective state Departments of Health.
Summary
Analysts view DaVita as a solid long-term investment due to its strong fundamentals, including a healthy balance sheet and strong financials. The company has been able to consistently increase its dividends and has also been able to expand its service offerings, resulting in an impressive return on investment for shareholders. Investors should be aware that DaVita’s stock can be volatile due to the market environment, but its strong financials and fundamentals provide solid upside potential for long-term investors.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
